Authors' response: pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

There is no fulltext present in this item.

Title:	Authors' response: pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
Author(s):	Nieuwlaat, W.A. ; Huysmans, D.A.K.C.; Hermus, A.R.M.M.
Publication year:	2003
Source:	Journal of Clinical Endocrinology and Metabolism, vol. 88, iss. 12, (2003), pp. 6114-6115
ISSN:	0021-972X
DOI:	https://doi.org/10.1210/jc.2003-031590
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/224577
Display more details
Subject:	UMCN 5.2: Endocrinology and reproduction
Organization:	Endocrinology Nuclear Medicine
Journal title:	Journal of Clinical Endocrinology and Metabolism
Volume:	vol. 88
Issue:	iss. 12
Page start:	p. 6114
Page end:	p. 6115